Neurodegenerative Disorders

Lecanemab for Alzheimers Disease: Reduces Amyloid-Beta Plaques But High ARIA Adverse Events (2024 Review)

by

Lecanemab shows promise in treating Alzheimer’s disease by reducing clinical deterioration and amyloid-beta plaques, but it has significant adverse effects and requires further research for confirmation. Highlights: FDA Approval: The US FDA authorized lecanemab for Alzheimer’s disease treatment in January 2023. Efficacy: Lecanemab significantly reduces clinical deterioration and amyloid-beta plaques in the brain. Adverse Effects: …

Read more

8 Plasma Biomarkers to Predict Parkinson’s Disease Up to 7 Years Before Motor Symptoms (2024 Study)

by

A study identified a panel of eight plasma biomarkers that can predict Parkinson’s disease up to seven years before motor symptoms appear. Highlights: Biomarker Panel: The study validated a panel of 8 proteins, including Granulin precursor and Complement C3, using mass spectrometry, which can differentiate Parkinson’s patients from healthy controls and identify pre-motor individuals with …

Read more

Herpes Zoster Vaccination Linked to Lower Dementia Risk (2024 Meta-Analysis)

by

TLDR: Herpes zoster vaccination is linked to a lower risk of dementia, but more studies are needed to confirm this association. Highlights: Five high-quality studies involving 103,615 vaccinated patients were analyzed. Herpes zoster vaccination was associated with a reduced risk of dementia (pooled odds ratio: 0.84). High variability among studies was observed, necessitating a random …

Read more

Gut Bacteria Abnormalities in Parkinson’s Disease: Global Analysis (2024)

by

TLDR: A study identified specific gut microbial features in Parkinson’s disease (PD) across different countries, highlighting increased α-diversity, altered bacterial species, and decreased metabolites in PD patients. Highlights: Increased α-Diversity: The study found higher α-diversity in PD patients across six datasets from different countries. Altered Bacterial Species: Species such as Akkermansia muciniphila were increased, while …

Read more

GLP-1 Receptor Agonists & Lower Dementia Risk in Older Adults with Diabetes (2024 Study)

by

TLDR: GLP-1 agonists were found to significantly reduce the risk of dementia in older individuals with type 2 diabetes mellitus (T2DM) compared to DPP-4 inhibitors and sulfonylureas. Highlights: A sequential trial emulation was conducted using data from Swedish national registers from 2010 to 2020, involving 88,381 participants aged 65 or older with T2DM. The incidence …

Read more

Peptide PHDP5 May Reverse Cognitive Impairment in Alzheimers Disease (2024 Research)

by

TLDR: Researchers demonstrated that intranasal administration of the peptide FITC-PHDP5-CPP reverses early cognitive impairment in Alzheimer’s disease (AD) model mice, showing potential as a treatment for AD-associated cognitive decline. Highlights: PHDP5, derived from the pleckstrin homology domain of dynamin 1, inhibits the interaction between dynamin and microtubules, rescuing synaptic dysfunction caused by tau accumulation. The …

Read more

High Salt Intake Linked to Alzheimers Disease & Dementia Risk in Europeans (2024 Study)

by

TLDR: This study provides evidence that high salt intake is causally associated with an increased risk of developing dementia, including Alzheimer’s disease (AD) and undefined dementia. Highlights: Causal Association: High salt intake is significantly associated with an increased risk of any dementia (OR = 1.73) and specifically Alzheimer’s disease (OR = 2.10). Cognitive Performance: Higher …

Read more

Methamphetamine Dependence Linked to Parkinson’s Disease Risk

by

New research reveals that people with a history of methamphetamine dependence face a startling elevated risk of developing Parkinson’s disease or related movement disorders later in life. Key Facts: Individuals dependent on methamphetamine had almost 3 times the rate of Parkinson’s outcomes compared to matched controls from the general population. For women with methamphetamine dependence, the risk …

Read more

CRISPR for Alzheimer’s Disease: Future Treatment via Gene Editing

by

Alzheimer’s disease continues to destroy minds, but new gene editing techniques like CRISPR offer hope for better understanding and treating this devastating illness. Key Facts: Alzheimer’s disease is a complex, poorly understood neurodegenerative disorder affecting over 50 million people worldwide. Gene mutations play a role in early-onset Alzheimer’s, but late-onset Alzheimer’s involves a more complex …

Read more

Transcranial Ultrasound Stimulation: Benefits & Future Applications

by

Our brains contain around 100 billion neurons communicating through an intricate web of connections. This complex circuitry controls everything we think, feel, and do. But sometimes things can go wrong, leading to neurological disorders like epilepsy, Parkinson’s disease, depression and Alzheimer’s. An exciting new approach called transcranial ultrasound stimulation (TUS) is showing great promise as …

Read more

+ Load more